Levetiracetam is a drug within the pyrrolidine class that is used to treat various types of seizures stemming from epileptic disorders. It was first approved for use in the United States in 1999 and is structurally and mechanistically unrelated to other anti-epileptic drugs (AEDs).[L8606,L8600,L8615] Levetiracetam possesses a wide therapeutic index[L8615,A185918] and little-to-no potential to produce, or be subject to, pharmacokinetic interactions[L8606,L8600,L8615] - these characteristics make it a desirable choice over other AEDs, a class of drugs notorious for having generally narrow therapeutic indexes and a propensity for involvement in drug interactions.[A185927]
Synonyms
Levetiracetame
Levetiracetam
Levetiracetamum
Brand Names
Levetiracetam 250 mg
Levetiracetam Micro
Matever
Pdp-levetiracetam
Ach-levetiracetam
Keppra XR
Sandoz Levetiracetam
Ava-levetiracetam
Levetiracetam Actavis Group
Pro-levetiracetam - 750
Roweepra
PMS-levetiracetam
Levetiracetam Actavis
Nu-levetiracetam
Nra-levetiracetam
Pro-levetiracetam - 500
Van-levetiracetam
LEVETIRACETAM Extended-release
Jamp Levetiracetam Tablets
Levetiracetam 1000 mg
Levetiracetam Accord
Levetiracetam in Sodium Chloride
Levetiracetam Teva
Teva-levetiracetam
Levetiracetam Hospira
Keppra
Levetiracetam
Mint-levetiracetam
Novo-levetiracetam
Nat-levetiracetam
Levetiracetam Extended Release
Elepsia XR 1000 mg
LEVETIRACETAM solution
Levetiractam
Spritam
Levetiracetam Extended-Release
Auro-levetiracetam
Levetiracetam 750 mg
Levetiracetam extended-release
Levetiracetam ER
Pharma-levetiracetam
PHL-levetiracetam
Riva-levetiracetam
Roweepra XR
Bio-levetiracetam
Levetiracetam Ratiopharm
Pro-levetiracetam - 250
Ran-levetiracetam
Torrent-levetiracetam
Levetiracetam Injection USP
Dom-levetiracetam
Levetiracetam Levetiracetam
Levetiracetam Sun
Jamp-levetiracetam
Priva-levetiracetam
Apo-levetiracetam
Levetiracetam Extended-release
Elepsia XR 1500 mg
M-levetiracetam
Levertiracetam
Elepsia XR
Ag-levetiracetam
Abbott-levetiracetam
Indication
Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606] Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]
Categories
Acetamides
Amides
Anticonvulsants
Central Nervous System Agents
Central Nervous System Depressants
Decreased Central Nervous System Disorganized Electrical Activity
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682